コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tum PCR-positive without confirmed/suspected bacterial pneumonia).
2 se (COPD)) as well as acute infections (e.g. bacterial pneumonias).
3 nces antimicrobial activity in gram-negative bacterial pneumonia.
4 ans organizing pneumonia after 2 episodes of bacterial pneumonia.
5 ity in the lung in response to Gram-negative bacterial pneumonia.
6 structure infections and community-acquired bacterial pneumonia.
7 es, during acute extracellular Gram-negative bacterial pneumonia.
8 n structure infection and community-acquired bacterial pneumonia.
9 activity is crucial for host defense against bacterial pneumonia.
10 penic recipient mice in both peritonitis and bacterial pneumonia.
11 ctions and enhanced development of secondary bacterial pneumonia.
12 h leptin contributes to host defense against bacterial pneumonia.
13 immunostimulatory strategy in patients with bacterial pneumonia.
14 uired for optimal host defense against acute bacterial pneumonia.
15 rn may contribute to disease pathogenesis of bacterial pneumonia.
16 ity and increase susceptibility to secondary bacterial pneumonia.
17 influenza pandemic were caused by secondary bacterial pneumonia.
18 efenses and inflammatory injury during acute bacterial pneumonia.
19 influx in human disease during Gram-negative bacterial pneumonia.
20 e to influenza sensitizes hosts to secondary bacterial pneumonia.
21 munity-acquired and nosocomial gram-negative bacterial pneumonia.
22 ormly exhibited severe changes indicative of bacterial pneumonia.
23 of C-reactive protein (CRP) for identifying bacterial pneumonia.
24 s could provide a novel mechanism to prevent bacterial pneumonia.
25 has been linked to an increased incidence of bacterial pneumonia.
26 ated with their ability to support secondary bacterial pneumonia.
27 ions for future efforts to prevent and treat bacterial pneumonia.
28 on; 9 patients recovered fully and 1 died of bacterial pneumonia.
29 at viruses contribute to the pathogenesis of bacterial pneumonia.
30 d to prevent excess mortality from secondary bacterial pneumonia.
31 nsin and inflammatory elements occurs during bacterial pneumonia.
32 munity-acquired and nosocomial gram-negative-bacterial pneumonia.
33 ght be useful in determining the presence of bacterial pneumonia.
34 deficiency of CD4 lymphocytes predisposes to bacterial pneumonia.
35 anges and tissue injury during-gram negative bacterial pneumonia.
36 ry end point was M. avium complex disease or bacterial pneumonia.
37 .16) were also significantly associated with bacterial pneumonia.
38 re not significantly associated with risk of bacterial pneumonia.
39 travenous TPN) would impair immunity against bacterial pneumonia.
40 ve treatment for patients with gram-negative bacterial pneumonia.
41 itial empiric treatment of hospital-acquired bacterial pneumonia.
42 nts, two patient groups with a high risk for bacterial pneumonia.
43 (PMNL) dysfunction and consequent secondary bacterial pneumonia.
44 tion, and incidence of ventilator-associated bacterial pneumonia.
45 tical illness, is clinically associated with bacterial pneumonia.
46 3 trials for treatment of community-acquired bacterial pneumonia.
47 n to facilitate the clearance and control of bacterial pneumonia.
48 andidiasis, tuberculosis, herpes zoster, and bacterial pneumonia.
49 ption for monotherapy for community-acquired bacterial pneumonia.
50 acterial pneumonia and ventilator-associated bacterial pneumonia.
51 effective as the parent stem cells in severe bacterial pneumonia.
52 cterial clearance, and survival after severe bacterial pneumonia.
53 nfluenza-induced susceptibility to secondary bacterial pneumonia.
54 ve edema formation and facilitated secondary bacterial pneumonia.
55 gently needed to protect the vulnerable from bacterial pneumonia.
56 , protein, and bacteria in mice injured with bacterial pneumonia.
57 infections, dehydration, heart failure, and bacterial pneumonia.
58 ed by a lethal dose of LPS or by Pseudomonas bacterial pneumonia.
59 ty and increases susceptibility to secondary bacterial pneumonia.
60 ngal colonization favored the development of bacterial pneumonia.
61 n and antimicrobial resistance in fungal and bacterial pneumonia.
62 ther bronchoalveolar lavage amylase predicts bacterial pneumonia.
63 eristic of perhaps all infections, including bacterial pneumonia.
64 risk factors for aspiration and may predict bacterial pneumonia.
65 , consequently, the prevalence of subsequent bacterial pneumonia.
66 pathogens known to cause community-acquired bacterial pneumonia.
67 from SP-B may be useful in the treatment of bacterial pneumonias.
68 s increased rates of bacteremia with certain bacterial pneumonias.
69 liminating and preventing the development of bacterial pneumonias.
70 women, 82540 [44.6%]; most common diagnosis bacterial pneumonia, 32634 [17.7%]), a total of 34578 pa
71 Among 119 HIV-negative cases with confirmed bacterial pneumonia, 77% had CRP >/=40 mg/L compared wit
72 mL ATP), viral infection (70 ng/mL ATP), and bacterial pneumonia (92 ng/mL ATP) were significantly di
73 greater in children with PCP than those with bacterial pneumonias (96 of 105 hospital days vs 15 of 9
74 sively studied in the arena of Gram-negative bacterial pneumonia, a role for T cells remains unknown.
78 ilure/rejection (aHR, 2.5; 95% CI, 1.5-4.1), bacterial pneumonia (aHR, 2.8; 95% CI, 2.0-3.9), viral p
79 tional clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin st
81 luenza A viruses can contribute to secondary bacterial pneumonia and deletions in the NA stalk may mo
82 ys an essential role in host defense against bacterial pneumonia and in leukocyte antibacterial effec
83 CRP was positively associated with confirmed bacterial pneumonia and negatively associated with RSV p
85 the human nasopharynx and a leading cause of bacterial pneumonia and otitis media, among other invasi
86 disease, the incidence of acute bronchitis, bacterial pneumonia and P. carinii pneumonia is high des
87 stages of HIV infection, incidence rates of bacterial pneumonia and P. carinii pneumonia rise contin
88 y distress such as malaria or distinguishing bacterial pneumonia and pneumonia from others causes, su
89 virus neuraminidase contributes to secondary bacterial pneumonia and subsequent excess mortality.
91 work in the indications of hospital-acquired bacterial pneumonia and ventilator-associated bacterial
92 ferent among the groups (p < .001), with the bacterial pneumonia and viral pneumonitis groups having
93 n ration (p < .001), and those patients with bacterial pneumonia and viral pneumonitis had decreased
94 re, and oxygen saturation than children with bacterial pneumonia and were less likely to have a focal
96 All 68 cases had histological evidence of bacterial pneumonia, and 94% showed abundant bacteria on
97 influenza B virus, characterize concomitant bacterial pneumonia, and describe the spectrum of cardio
98 D4 counts < 200 cells/mm3, acute bronchitis, bacterial pneumonia, and P. carinii pneumonia occurred a
103 One hundred fifteen (76%) responders chose bacterial pneumonia as a condition consistent with infil
104 sis, prophylaxis, and treatment of secondary bacterial pneumonia, as well as stockpiling of antibioti
105 possible contributor to the common secondary bacterial pneumonia associated with pandemic and seasona
107 eumocystis carinii pneumonia (PCP), but also bacterial pneumonia (BP), result in reductions in lung f
108 negatively regulates CXCL1/KC levels during bacterial pneumonia but that the role of GRK5 in the cli
109 orted that leptin plays a protective role in bacterial pneumonia, but the mechanisms by which leptin
110 t M-CSF is critical to host defenses against bacterial pneumonia by mediating survival and antimicrob
111 lpha-Toc enhances resistance of aged mice to bacterial pneumonia by modulating the innate immune resp
112 nistration for therapy of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and
114 infections (ABSSSIs) and community-acquired bacterial pneumonia (CABP) were based on nonstandardized
118 emic likely resulted directly from secondary bacterial pneumonia caused by common upper respiratory-t
119 learly and consistently implicated secondary bacterial pneumonia caused by common upper respiratory-t
121 o determine the role of TNF in gram-negative bacterial pneumonia, CBA/J mice were challenged with 10(
123 which was defined as a composite endpoint of bacterial pneumonia (confirmed by the endpoint review co
124 sion rates for all types of ACSCs, including bacterial pneumonia, congestive heart failure, dehydrati
126 ion of new mechanisms in the pathogenesis of bacterial pneumonia could lead to future therapeutic tar
128 n of 16 children with PCP and six of 21 with bacterial pneumonia died (relative risk 2.19 [95% CI 1.0
130 concentration (p=0.004), and more cumulative bacterial pneumonia episodes (12 month lag only; p trend
131 these factors, CD4/CD8 ratio and cumulative bacterial pneumonia episodes remained significant (p tre
134 ed as a diagnostic marker in differentiating bacterial pneumonia from other respiratory conditions su
135 athways, including facilitation of secondary bacterial pneumonia from pathogens such as Streptococcus
137 n hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) is caused by gram-positi
138 f hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) is often multidrug-resis
141 nnate immune responses, as in the setting of bacterial pneumonia, has been incompletely characterized
143 e assessed incidence of and risk factors for bacterial pneumonia in 1,898 human immunodeficiency viru
145 lear phagocyte-mediated host defenses during bacterial pneumonia in a murine model of infection.
148 CN2 levels were tremendously elevated during bacterial pneumonia in humans, and high LCN2 levels were
151 o determine its role in host defense against bacterial pneumonia in vivo and in alveolar macrophage (
152 nees/military recruits were due to secondary bacterial pneumonias; in contrast, most deaths among Rot
153 Other mediators of innate immunity against bacterial pneumonia include transepithelial dendritic ce
155 ce rates (IRs) per 100 person-years were 123 bacterial pneumonia (IR, 2.15; 95% confidence interval [
172 f the pathogenesis of, and risk factors for, bacterial pneumonia is critical to the development of st
173 plasma from patients with ARDS secondary to bacterial pneumonia is toxic to SPAEC, and a small but s
177 reptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and sepsis in children
178 y the role of specific T cell populations in bacterial pneumonia, mice deleted of their TCR beta- and
179 oniae (the pneumococcus) is a major cause of bacterial pneumonia, middle ear infection (otitis media)
180 dase (MPO) colocalized with SP-D in a murine bacterial pneumonia model of acute inflammation, suggest
181 sublethal hyperoxia increases Gram-negative bacterial pneumonia mortality and has a significant adve
182 ltiple pathogens, e.g., the life-threatening bacterial pneumonia observed in patients infected with i
185 associated with significantly lower odds of bacterial pneumonia (odds ratio 0.39, 95% confidence int
186 ptococcus pneumoniae is a causative agent of bacterial pneumonia, otitis media, meningitis, and bacte
187 buted to influenza virus is due to secondary bacterial pneumonia, particularly from Streptococcus pne
188 total of 863 adults with community-acquired bacterial pneumonia (Pneumonia Outcomes Research Team [P
189 specificity of elevated CRP for "confirmed" bacterial pneumonia (positive blood culture or positive
191 five in the placebo group (1.9 percent) had bacterial pneumonia (relative risk in the azithromycin g
196 e transgenic expression of MIP-1alpha during bacterial pneumonia resulted in enhanced expression of g
197 been a dramatic decline in the incidence of bacterial pneumonia resulting from the use of combinatio
198 mens was associated with a decreased risk of bacterial pneumonia (risk ratio [RR] 0.55, 95% CI 0.31 t
199 a well-established murine model of secondary bacterial pneumonia (SBP) following influenza, we strati
200 nt of 37.1 mg/L best discriminated confirmed bacterial pneumonia (sensitivity 77%) from RSV pneumonia
201 Streptococcus (GBS) is the leading cause of bacterial pneumonia, sepsis, and meningitis among neonat
203 Legionella pneumophila, a causative agent of bacterial pneumonia, survives inside phagocytic cells by
205 infection predisposes patients to secondary bacterial pneumonia that contributes significantly to mo
206 on model of the intrahost immune response to bacterial pneumonia that is capable of capturing diverse
207 icient mice display impaired host defense in bacterial pneumonia that may be due to a defect in alveo
208 ased morbidity and mortality associated with bacterial pneumonias that are acquired following influen
209 al pneumopathogens and can lead to secondary bacterial pneumonias that greatly contribute to respirat
210 o a significant number of cases of secondary bacterial pneumonia, this highly pathogenic strain of in
211 cases are viral, it is important to identify bacterial pneumonia to provide appropriate therapy.
213 ns were much the same as in controls: 18 had bacterial pneumonia, two tuberculosis, five cryptococcal
214 or of inflammation in a mouse model of acute bacterial pneumonia using the opportunistic bacterial pa
215 flox)) to littermate controls during direct (bacterial pneumonia, ventilator-induced ALI, bleomycin-i
216 une response that favored the development of bacterial pneumonia via the inhibition of bacterial phag
217 ia, infection with Cryptococcus or Nocardia, bacterial pneumonia, viral pneumonia, and Kaposi's sarco
219 actant protein A were noted in children with bacterial pneumonia, viral pneumonitis, and ARDS, but no
221 aspirates were collected from children with bacterial pneumonia, viral pneumonitis, ARDS, postcardio
225 ip of combination antiretroviral therapy and bacterial pneumonia, we assessed incidence of and risk f
226 mine the role of MyD88 in innate immunity to bacterial pneumonia, we exposed MyD88-deficient and wild
227 the lung in response to LPS or Gram-negative bacterial pneumonia, we hypothesized that IL-17RA signal
228 new approaches to enhance innate immunity to bacterial pneumonia, we investigated the natural experim
231 filtrates on chest radiographs suggestive of bacterial pneumonia were common among those needing hosp
234 c influenza predispose patients to secondary bacterial pneumonias, which are a major cause of deaths
235 icillin-resistant pneumococci) suggests that bacterial pneumonia will assume increasing importance in
236 ion was characterized by viral and secondary bacterial pneumonia with 67% having positive RT-PCR in s
239 ned as documented bacteremia or any presumed bacterial pneumonia with or without positive respiratory
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。